Filter
226
Text search:
pharmacological
interventions
Featured
Recommendations
36
New Publications
38
Language
Document type
No document type
135
Guidelines
34
Studies & Reports
22
Manuals
15
Training Material
7
Strategic & Response Plan
6
Fact sheets
5
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
11
India
8
Kenya
8
Western and Central Europe
8
South Africa
6
Latin America and the Carribbean
6
Eastern Europe
5
Rwanda
4
Nigeria
3
Ethiopia
3
Asia
3
Uganda
2
Zimbabwe
2
Syria
2
Ukraine
2
Russia
2
Guinea
1
Sierra Leone
1
Liberia
1
Senegal
1
Ghana
1
Philippines
1
Nepal
1
South Sudan
1
Jordan
1
Germany
1
Tanzania
1
Cambodia
1
Bangladesh
1
Papua New Guinea
1
Peru
1
Eswatini/ Swaziland
1
Hungary
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Africa
1
Poland
1
Uzbekistan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
44
Clinical Guidelines
35
Public Health
15
Women & Child Health
13
Capacity Building
3
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
Mental Health
92
NCDs
17
COVID-19
9
TB
8
Caregiver
7
Pharmacy
7
HIV
6
AMR
6
Refugee
4
NTDs
3
Disability
2
Conflict
2
Planetary Health
2
Ebola & Marburg
1
Polio
1
Natural Hazards
1
Zika
1
Specific Hazards
1
Global Health Education
1
Social Ethics
1
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal
...
Psiquiatría y pediatría
Capítulo I.4
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Juan Jairo Ortiz Guerra
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influenza A) viruses.
Anxiety disorders
Chapter F.5
Training of Health-care Providers and Training manual Supporting material
These guidelines have been developed specifically to address ethical issues of conducting research in children.
4th edition. A manual for clinics, community health centers and district hospitals
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an
...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple
...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no
...
